Psychiatry & Neurology Doctors in Madison, NJ Accepting Medicare

6 Psychiatry & Neurology doctors found. Showing 1 - 6

Dr. Richard Michael Di Turi, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 214 Main St, Madison, NJ 07940 Phone: 973-765-9500    Fax: 973-765-9502

Dr. Manjula Bathini, D.O. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 300 Madison Ave, Suite 201, Madison, NJ 07940 Phone: 973-822-2772    Fax: 973-822-2773

Dr. Linda Marie Brzustowicz, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 40 Green Ave, Madison, NJ 07940 Phone: 862-368-1153

Dr. Bryan William Fennelly, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 8 Shunpike Rd, Suite 9, Madison, NJ 07940 Phone: 973-660-0084    Fax: 973-966-0332

Omar Canosa, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 37 Kings Rd, Ste 202, Madison, NJ 07940 Phone: 973-520-8848    Fax: 973-200-8088

Dr. Maribel Abbate, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 300 Main St # 508, Madison, NJ 07940 Phone: 973-847-2120    Fax: 973-847-2121

News Archive

Study: Immunosuppressed patients with sepsis more likely to die during hospitalization

Immunosuppressed patients with sepsis appear more likely to die if they are treated in a hospital caring for a relatively small number of these patients, according to new research published online in the Annals of the American Thoracic Society.

Researchers discover potential new therapeutic target for treating obesity

Scientists at Baylor College of Medicine, the National Institutes of Health and Virginia Tech Carilion Research Institute have discovered a new mechanism in the mouse brain that regulates obesity.

FDA approves FASLODEX 500mg dose for metastatic breast cancer in postmenopausal women

AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has approved the 500mg dose of FASLODEX® (fulvestrant) Injection, replacing the previously approved monthly dose of 250mg, for the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.

Oxysterol derivatives show powerful antiviral activity against SARS-CoV-2 in vitro

A new study describes the antiviral activity of oxysterols, or oxidized cholesterol derivatives, against SARS-CoV-2. These occur in nature, and are not only involved in lipid signaling pathways that modulate a host of processes within the body, including the immune response and lipid homeostasis.

Retinal venular calibre predicts ranibizumab vision improvement

Retinal venular calibre may predict visual outcome in diabetic macular oedema patients given the anti-vascular endothelial growth factor monoclonal antibody ranibizumab, a pilot study suggests.

Read more Medical News

› Verified 8 days ago